<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): September 1, 2000
OXBORO MEDICAL, INC.
--------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
MINNESOTA 0-18785 41-1391803
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
13828 Lincoln Street NE
Ham Lake, Minnesota 55304
------------------------ ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (763) 755-9516
<PAGE>
Item 2. ACQUISITION OR DISPOSITION OF ASSETS
Through a series of purchases, Oxboro Medical, Inc. (the "Company") has
acquired 200,000 shares of common stock of Minntech Corporation (NasdaqNM: MNTX)
as of September 14, 2000. Minntech Corporation develops, manufactures and
markets medical devices, sterilants, and water purification products. The
Company paid approximately $1.35 million in total consideration for the 200,000
shares, all of which was financed from the working capital of the Company. As of
July 1, 2000 Minntech Corporation had approximately 6,678,016 outstanding shares
of common stock, as reported in Minntech Corporation's Form 10-Q for the quarter
ended July 1, 2000 as filed with the Securities and Exchange Commission. The
management of the Company continues to consider all strategies to maximize value
for the Company's shareholders, including, but not limited to, additional
purchases of Minntech Corporation stock should market conditions warrant such
purchases. The Company has no relationship to Minntech Corporation other than
that of shareholder. All shares were purchased in open market transactions.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
OXBORO MEDICAL, INC.
By /s/ Linda Erickson
--------------------------------------
Linda Erickson, Chief Financial Officer
Dated: September 15, 2000.
3
